Top

Published in:

Open Access 01-06-2018 | Commentary

A Commentary on Commercial Genetic Testing and the Future of the Genetic Counseling Profession

Authors: Nicholas D. Wolff, Jon A. Wolff

Published in: Journal of Genetic Counseling | Issue 3/2018

Abstract

Commercial genetic testing laboratories are increasingly employing genetic counselors. As a result, the role of these or many genetic counselors is shifting from primarily direct patient counseling in clinics and hospitals to more laboratory-centered activities that involve case coordination, customer liaison, variant classification, marketing, and sales. Given the importance of these commercial entities to the genetic counseling profession, this commentary examines the current financial situation of four publicly traded, genetic testing companies. It also explores how the various roles of genetic counselors are likely to be affected by the financial pressures these companies face.

Annas, G. J., & Elias, S. (2014). 23andMe and the FDA. New England Journal of Medicine, 370(11), 985–988. https://doi.org/10.1056/NEJMp1316367.CrossRefPubMed

CombiMatrix. (2016). Form 10-K 2016. Retrieved from https://www.sec.gov/edgar.shtm.

Concert Genetics (2016). A guide to BRCA testing for health plans. Retrieved from http://concertgx.wpengine.com/wp-content/uploads/2017/02/ConcertGenetics_AGuidetoBRCATestingforHealthPlans_November2016.pdf.

Cook-Deegan, R., & Niehaus, A. (2014). After myriad: genetic testing in the wake of recent supreme court decisions about gene patents. Current Genetic Medicine Reports, 2(4), 223–241. https://doi.org/10.1007/s40142-014-0055-5l.CrossRefPubMedPubMedCentral

Farr, C., (2016). Genetics startup helix wants to create a world of personalized products from your DNA. Retrieved from https://www.fastcompany.com/3065413/genetics-startup-helix-wants-to-create-a-world-of-personalized-products-from-your-dna. Accessed 11 May 2017

FDA. (2017). Press announcements—FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions. Retrieved from https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm551185.htm. Accessed 11 May 2017

Free the Data. (n.d.). Retrieved from http://www.free-the-data.org/. Accessed 11 May 2017

Gabai-Kapara, E., Lahad, A., Kaufman, B., Friedman, E., Segev, S., Renbaum, P., et al. (2014). Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proceedings of the National Academy of Sciences, 111(39), 14205–14210. https://doi.org/10.1073/pnas.1415979111.CrossRef

Guerrini, C. J., McGuire, A. L., & Majumder, M. A. (2017). Myriad take two: can genomic databases remain secret? Science, 356(6338), 586–587.CrossRefPubMed

Harris, R. (n.d.). Electronic health records may help customize medical treatments. Retrieved from http://www.npr.org/sections/health-shots/2017/01/09/508241690/electronic-health-records-may-help-customize-medical-treatments. Accessed 11 May 2017

Herper, M. (n.d.). In Big Shift, 23andMe will invent drugs using customer data. Retrieved from http://www.forbes.com/sites/matthewherper/2015/03/12/23andme-enters-the-drug-business-just-as-apple-changes-it/. Accessed 11 May 2017

Illumina, Inc. (2017) Illumina Introduces the NovaSeq Series—new architecture designed to usher in the $100 genome. (2017). Retrieved from http://www.businesswire.com/news/home/20170109006363/en/Illumina-Introduces-NovaSeq-Series%E2%80%94a-Architecture-Designed-Usher. Accessed 11 May 2017

Invitae. (2016). Form 10-K 2016. Retrieved from https://www.sec.gov/edgar.shtml.

Invitae|Patients Home. (n.d.). Retrieved from https://www.invitae.com/en/patients-home/. Accessed 11 May 2017

Mackison, A., & Stoll, K. (2016). The changing landscape of genetic counselors licensed in Washington State (2011–2015). (2016). Poster session presented at the Annual Education Conference of the National Society of Genetic Counselors, Seattle, WA.

Natera (n.d.) My Natera—patient portal. Retrieved from https://my.natera.com/get_test/request_test. Accessed 11 May 2017

Myriad. (2016). Form 10-K 2016. Retrieved from https://www.sec.gov/edgar.shtml.

Natera. (2016). Form 10-K 2016. Retrieved from https://www.sec.gov/edgar.shtml.

NSGC. (2016). Professional status survey. Retreived from https://www.nsgc.org/p/cm/ld/fid=68.

Pollock, A. (2012). Conflict potential seen in genetic counselors. New York Times. Retrieved from http://www.nytimes.com/2012/07/14/business/conflict-potential-seen-in-genetic-counselors-paid-by-testing-companies.html.

Strom, C. M. (2012). Changing trends in laboratory testing in the United States. Conceptual Advances in Pathology, 32(4), 651–664. https://doi.org/10.1016/j.cll.2012.07.003.

Waltman, L., Runke, C., Balcom, J., Riley, J. D., Lilley, M., Christian, S., & Goodenberger, M. L. (2016). Further defining the role of the laboratory genetic counselor. Journal of Genetic Counseling, 25(4), 786–798. https://doi.org/10.1007/s10897-015-9927-4.CrossRefPubMed

Title: A Commentary on Commercial Genetic Testing and the Future of the Genetic Counseling Profession
Authors: Nicholas D. Wolff
Jon A. Wolff
Publication date: 01-06-2018
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 3/2018
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-018-0244-6

At a glance: The STEP trials

Springer Medicine

A Commentary on Commercial Genetic Testing and the Future of the Genetic Counseling Profession

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

Commentary on “Commercial Genetic Testing and the Future of the Genetic Counseling Profession”

Making Sense of SNPs: Women’s Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks

Psychosocial Distress and Knowledge Deficiencies in Parents of Children in Ireland Who Carry an Altered Cystic Fibrosis Gene

Caregiver Quality of Life with Tyrosinemia Type 1

The Genetic Counselor in the Pediatric Arrhythmia Clinic: Review and Assessment of Services

Limitations and Pitfalls of Using Family Letters to Communicate Genetic Risk: a Qualitative Study with Patients and Healthcare Professionals